Dr. Peter Marks

Dr. Peter Marks is the director of the FDA's Center for Biologics Evaluation and Research (CBER), where he oversees the regulation of vaccines, gene therapies, and other biological products. A board-certified hematologist and oncologist, he previously held leadership roles in academia and the biopharmaceutical industry.